Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hubei Qianlong Pharmaceutical is a Chinese pharmaceutical enterprise focused on the research, development, and large-scale production of chemical drugs and traditional Chinese medicines. Based in Qianjiang, Hubei Province, the company maintains multiple GMP-certified production lines for dosage forms including tablets, capsules, and granules. Its commercial portfolio is particularly strong in gastrointestinal treatments, anti-infectives, and respiratory medications. The company serves the domestic Chinese market by providing essential medicines and high-quality generic formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hubei Qianlong Pharmaceutical.